COMP <GO>
CP vs TMO // 10Y YIELD & FRED MACRO BETA
Canadian Pacific Kansas City Limited (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CP 4
— TMO 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: CP
LAST: $89.68 (+1.48%) • MKT CAP: $76.84B
macro-sensitivity
1.07
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CP VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CP | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 9.30% | +0.60 | CP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 30.4x | -9.40 | CP | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.40% | -0.19 | TMO | /fcf-yield <GO> |
| Operating Margin | 13.90% | 17.40% | -3.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 15.10% | -4.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 3.90% | -1.70 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 4.50 | -0.76 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.70% | +0.40 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.1 | 59.1 | -3.07 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.07 | 0.94 | +0.13 | CP | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 36.3x | -5.80 | CP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $76.84B | $262.22B | -$185.37B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CP REV | TMO REV | CP GROSS % | TMO GROSS % | CP FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $44.56B | — | 44.0% | — | $6.29B |
| FY 2024 | — | $42.88B | — | 44.0% | — | $7.27B |
| FY 2023 | — | $42.86B | — | 44.0% | — | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CP // BETA 1.07
TMO // BETA 0.94